420 likes | 535 Views
Immunology (elective) MLIM-101. Prepared by: Dr. Mohamed S. Abdel- Latif. Complements. Learning Outcome:. At this time you should know the following: 1. Proteins of the complement system. 2. Differences and similarities among the different pathways of C3 activation.
E N D
Immunology (elective)MLIM-101 Prepared by: Dr. Mohamed S. Abdel-Latif
Learning Outcome: At this time you should know the following: 1. Proteins of the complement system. 2. Differences and similarities among the different pathways of C3 activation. 3. Significance of the different pathways in specific and nonspecific immunity. 4. Role of different complement activation products in amplification of nonspecific and specific immunity and inflammation.
Complement:history Discovered in 1894 by Bordet It represents lytic activity of fresh serum Its lytic activity destroyed when heated at 56C for 30 min
Complement functions • Host benefit: • opsonization to enhance phagocytosis • phagocyte attraction and activation • lysis of bacteria and infected cells • regulation of antibody responses • clearance of immune complexes • clearance of apoptic cells • Host detriment: • Inflammation, anaphylaxis
Definitions • C-activation: alteration of C proteins such that they interact with the next component • C-fixation: utilization of C by Ag-Ab complexes • Hemolytic units (CH50): dilution of serum which lyses 50% of Ab-coated r.b.c in a suspension • C-inactivation: denaturation (usually by heat) of an early C-component resulting in loss of hemolytic activity • Convertase/esterase: altered C-protein which acts as a proteolytic enzyme for another C-component
Proteins of the complementsystem (nomenclature) • C1(qrs), C2, C3, C4, C5, C6, C7, C8, C9 • factors B, D, H and I, properdin (P) • mannose binding lectin (MBL), MBL associated serine proteases (MASP-1 MASP-2) • C1 inhibitor (C1-INH, serpin), C4-binding protein (C4-BP), decay accelerating factor (DAF), • C1 receptor (CR1), protein-S (vitronectin)
Activated component are usually over-lined: e.g. C1qrs Activation product of complement proteins (nomenclature) When enzymatically cleaved, the larger moiety, binds to the activation complex or membrane and the smaller peptide is released in the microenvironment Letter “b” is usually added to the larger,membrane-binding, peptide and “a” to the smaller peptide (e.g., C3b/C3a, C4b/C4a, C5b/C5a), EXCEPT C2 (the larger, membrane-binding moiety is C2a; the smaller on is C2b)
antibody independent antibody dependent Activation of C3 and generation of C5 convertase activation of C5 LYTIC ATTACK PATHWAY Pathways of complement activation LECTIN PATHWAY ALTERNATIVE PATHWAY CLASSICAL PATHWAY
C1r C1s C1q Ca++ Components of the Classical Pathway C4 C2 C3 C1 complex
C4a C1r C1s C1q b Ca++ Classical Pathway Generation of C3-convertase C4
C2b C1r C1s a C1q Ca++ C2 a Classical Pathway Generation of C3-convertase C2 C4a Mg++ C4b2a is C3 convertase C4b
C1r C3a C1s C1q Ca++ C2 a b Classical Pathway Generation of C5-convertase C2b C4a C4b2a3b is C5 convertase; it leads into the Membrane Attack Pathway Mg++ C3 C4b
MBL Components of mannose-binding lectin pathway C4 MASP2 C2 MASP1
C2a C2a C2b C4a C4b C4b MBL Mannose-binding lectin pathway C4b2a is C3 convertase; it will lead to the generation of C5 convertase C4 C2 MASP2 MASP1
Components of thealternative pathway D C3 B P
b i b C3a Spontaneous C3 activation Generation of C3 convertase D H2O B C3 C3 C3iBb complex has a very short half life
C3b b b C3a C3-activationthe amplification loop If spontaneously-generated C3b is not degraded D B C3
C3b b b Bb C3b C3a C3-activationthe amplification loop D B C3 C3a
Bb C3b C3b b b Bb C3b C3a C3-activationthe amplification loop D B C3 C3a C3a
Bb Bb C3b C3b C3b Bb C3b C3-activationthe amplification loop C3a C3a C3a
Bb Bb C3b C3b Bb C3b C3-activationthe amplification loop C3a C3a C3a
C3b DAF CR1 Autologous cell membrane Control of spontaneousC3 activation via DAF DAF prevents the binding of factor B to C3b B
B C3b b B b b DAF CR1 Autologous cell membrane Control of spontaneousC3 activation via DAF DAF dislodges C3b-bound factor Bb
DAF B b B b C3b C3b CR1 CR1 iC3b iC3b Control of spontaneousC3 activation via CR1 H I I DAF Autologous cell membrane
C3c C3c C3dg C3dg C3b C3b I I iC3b iC3b Degradation of spontaneously produced C3b
C3a C3b finds an activator (protector) membrane C3b b b C3b stabilization andC5 activation This is stable C5 convertase of the alternative pathway D P B C3
C2a C3b C4b C5-convertase of the two pathways C5-convertase of the Classical and lectin Pathways C5-convertase of the Alternative Pathway Bb C3b C3b
Lytic pathway Generation of C5 convertase leads to the activation of the Lytic pathway
C8 C7 Components of the lytic pathway C6 C5 C 9
C5a b C3b C4b C2 a Lytic pathwayC5-activation C5
C7 C5 b Lytic pathwayassembly of the lytic complex C6
C8 C6 C7 C5 b Lytic pathway:insertion of lytic complex into cell membrane C 9 C 9 C 9 C 9 C 9 C 9 C 9 C 9 C 9
C1r C1r C1s C1s C1q C1qrs breakdown C1Inh
Product Biological Effects Regulation C2b (prokinin) edema C1-INH C3a (anaphylatoxin) carboxy-peptidase- B (C3-INA) mast cell degranulation; enhanced vascular permeability; anaphylaxis Biological properties of C-activation products
Product Biological Effects Regulation C3b (opsonin) opsonization; phagocyte activation factors H & I C4a (anaphylatoxin) as C3, but less potent (C3-INA) C4b (opsonin) opsonization; phagocytosis C4-BP, factor I Biological properties of C-activation products
Product Biological Effects Regulation C5a (chemotactic factor) anaphylactic as C3, but much more potent; attracts & activates PMN causes neutrophil aggregation, stimulation of oxidative metabolism and leukotriene release carboxy-peptidase-C (C3-INA) C5b67 chemotaxis, attaches to other membranes protein-S Biological properties of C-activation products
Assignment: As a part of the semester activity, group of students are selected every week to prepare a short seminar about his/her point of interest in one of the lecture topics. That to be discussed and evaluated during the next lecture.